BLUEJAY DIAGNOSTICS INC (BJDX) Fundamental Analysis & Valuation

NASDAQ:BJDX • US0956336087

Current stock price

1.78 USD
-0.03 (-1.66%)
Last:

This BJDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BJDX Profitability Analysis

1.1 Basic Checks

  • In the past year BJDX has reported negative net income.
  • BJDX had a negative operating cash flow in the past year.
  • In the past 5 years BJDX always reported negative net income.
  • In the past 5 years BJDX always reported negative operating cash flow.
BJDX Yearly Net Income VS EBIT VS OCF VS FCFBJDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • BJDX has a worse Return On Assets (-96.20%) than 81.38% of its industry peers.
  • Looking at the Return On Equity, with a value of -114.61%, BJDX is doing worse than 67.55% of the companies in the same industry.
Industry RankSector Rank
ROA -96.2%
ROE -114.61%
ROIC N/A
ROA(3y)-205.07%
ROA(5y)-140.12%
ROE(3y)-274.65%
ROE(5y)-184.33%
ROIC(3y)N/A
ROIC(5y)N/A
BJDX Yearly ROA, ROE, ROICBJDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

  • BJDX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BJDX Yearly Profit, Operating, Gross MarginsBJDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BJDX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BJDX has been increased compared to 1 year ago.
  • BJDX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BJDX has an improved debt to assets ratio.
BJDX Yearly Shares OutstandingBJDX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50K 100K 150K
BJDX Yearly Total Debt VS Total AssetsBJDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • BJDX has an Altman-Z score of -9.69. This is a bad value and indicates that BJDX is not financially healthy and even has some risk of bankruptcy.
  • BJDX has a Altman-Z score of -9.69. This is amonst the worse of the industry: BJDX underperforms 80.32% of its industry peers.
  • BJDX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, BJDX is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.69
ROIC/WACCN/A
WACCN/A
BJDX Yearly LT Debt VS Equity VS FCFBJDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • BJDX has a Current Ratio of 4.88. This indicates that BJDX is financially healthy and has no problem in meeting its short term obligations.
  • BJDX's Current ratio of 4.88 is fine compared to the rest of the industry. BJDX outperforms 74.47% of its industry peers.
  • A Quick Ratio of 4.88 indicates that BJDX has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 4.88, BJDX is doing good in the industry, outperforming 79.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
BJDX Yearly Current Assets VS Current LiabilitesBJDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BJDX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.62% over the past year.
EPS 1Y (TTM)97.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year55.56%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BJDX Yearly Revenue VS EstimatesBJDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2025 2026 2M 4M 6M 8M
BJDX Yearly EPS VS EstimatesBJDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

0

4. BJDX Valuation Analysis

4.1 Price/Earnings Ratio

  • BJDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BJDX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BJDX Price Earnings VS Forward Price EarningsBJDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BJDX Per share dataBJDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BJDX Dividend Analysis

5.1 Amount

  • BJDX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BJDX Fundamentals: All Metrics, Ratios and Statistics

BLUEJAY DIAGNOSTICS INC

NASDAQ:BJDX (4/10/2026, 8:08:01 PM)

1.78

-0.03 (-1.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-28
Earnings (Next)N/A
Inst Owners4.07%
Inst Owner Change0%
Ins Owners2.38%
Ins Owner Change0%
Market Cap1.83M
Revenue(TTM)N/A
Net Income(TTM)-6.85M
Analysts43.33
Price TargetN/A
Short Float %6.19%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)-65.48
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-6.05
FCFYN/A
OCF(TTM)-5.88
OCFYN/A
SpS0
BVpS5.8
TBVpS5.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -96.2%
ROE -114.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-205.07%
ROA(5y)-140.12%
ROE(3y)-274.65%
ROE(5y)-184.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 234.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z -9.69
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)249.49%
Cap/Depr(5y)302.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.96%
EPS Next Y9.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year55.56%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.59%
OCF growth 3YN/A
OCF growth 5YN/A

BLUEJAY DIAGNOSTICS INC / BJDX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BJDX.


What is the valuation status of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

ChartMill assigns a valuation rating of 0 / 10 to BLUEJAY DIAGNOSTICS INC (BJDX). This can be considered as Overvalued.


Can you provide the profitability details for BLUEJAY DIAGNOSTICS INC?

BLUEJAY DIAGNOSTICS INC (BJDX) has a profitability rating of 0 / 10.


What is the financial health of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

The financial health rating of BLUEJAY DIAGNOSTICS INC (BJDX) is 4 / 10.


What is the expected EPS growth for BLUEJAY DIAGNOSTICS INC (BJDX) stock?

The Earnings per Share (EPS) of BLUEJAY DIAGNOSTICS INC (BJDX) is expected to grow by 9.38% in the next year.